Chief Executive Officer
Michael brings more than 30 years of experience in financial services, initially as a broker with several national broker-dealers and as an investment banker. Michael currently serves as the President and Co-Founder of Deverra Therapeutics. Throughout his career, Michael has served on multiple public and private boards and has been involved in several M&A transactions. Michael currently runs his own Family Office, which focuses on making investments in the Life Science industry.
Chief Scientific Officer
Tanya has more than 30 years of experience in global pharmaceutical development and innovation. She holds a Masters Degree with a major in Technology Management from the University of Miami and graduated with honors in Chemistry from Hull University, England. Tanya also completed the full research for a PhD in Molecular Orbital Computational Stereochemistry.
Chief Financial Officer
Since 2012, Jeremy has served as the CFO of Innoveren Scientific, where he co-leads vision, strategy and execution of all facets of financial, operations, strategic planning and organizational development. He earned a bachelor’s degree in business administration from the University of Cincinnati and an MBA from Xavier University.
© 2024 Innoveren Scientific Inc. All Rights Reserved. Powered by Issuer Direct.
IVRN@alpha-ir.com
312-445-2870
151 W 4th St. Ste 223
Cincinnati, OH 45202